Cargando…

Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer

Triple-negative breast cancer (TNBC) is a highly heterogeneous disease defined by the absence of estrogen receptor (ER) and progesterone receptor (PR) expression, and human epidermal growth factor receptor 2 (HER2) overexpression that lacks targeted treatments, leading to dismal clinical outcomes. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ensenyat-Mendez, Miquel, Llinàs-Arias, Pere, Orozco, Javier I. J., Íñiguez-Muñoz, Sandra, Salomon, Matthew P., Sesé, Borja, DiNome, Maggie L., Marzese, Diego M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242253/ https://www.ncbi.nlm.nih.gov/pubmed/34221999 http://dx.doi.org/10.3389/fonc.2021.681476

Ejemplares similares

Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer
por: Llinàs-Arias, Pere, et al.
Publicado: (2021)

Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2023)

Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2023)

Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology
por: Sesé, Borja, et al.
Publicado: (2021)

Correction to: Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology
por: Sesé, Borja, et al.
Publicado: (2021)

Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors
por: Llinàs-Arias, Pere, et al.
Publicado: (2023)

Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive Phenotype
por: Sesé, Borja, et al.
Publicado: (2022)

iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2021)

Correction to: iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2021)

3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer
por: Llinàs-Arias, Pere, et al.
Publicado: (2023)

Genome-wide chromatin accessibility, DNA methylation and gene expression analysis of histone deacetylase inhibition in triple-negative breast cancer
por: Bustos, Matias A., et al.
Publicado: (2017)

Microbial Dysbiosis Is Associated with Human Breast Cancer
por: Xuan, Caiyun, et al.
Publicado: (2014)

Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication
por: Krishna, Vikram, et al.
Publicado: (2020)

Beyond the immediate tumor microenvironment: distinct T cell phenotype and function of tumor-adjacent healthy breast tissue associated with regional metastasis in breast cancer
por: Guo, Yi, et al.
Publicado: (2014)

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers
por: Turdo, Federica, et al.
Publicado: (2016)

Correlated MR spectroscopic imaging of breast cancer to investigate metabolites and lipids: acceleration and compressed sensing reconstruction
por: Joy, Ajin, et al.
Publicado: (2022)

Methylation profile of triple-negative breast carcinomas
por: Branham, M T, et al.
Publicado: (2012)

Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells
por: Carrier, Arnaud, et al.
Publicado: (2022)

How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support
por: Berkowitz, Maurice J., et al.
Publicado: (2020)

A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer
por: Nguyen, Vina P., et al.
Publicado: (2023)

Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer
por: Borges, Bruna Cristina, et al.
Publicado: (2022)

Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Disintegrin-like Protein Strategy to Inhibit Aggressive Triple-Negative Breast Cancer
por: Limam, Inès, et al.
Publicado: (2023)

Presentation and treatment of aggressive, Triple‐Negative carcinosarcoma of the breast
por: Vizgan, Niels, et al.
Publicado: (2022)

STXBP6, reciprocally regulated with autophagy, reduces triple negative breast cancer aggressiveness
por: Lenka, Govinda, et al.
Publicado: (2020)

Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment
por: Winter, Marie, et al.
Publicado: (2021)

MiR-150-5p Overexpression in Triple-Negative Breast Cancer Contributes to the In Vitro Aggressiveness of This Breast Cancer Subtype
por: Sugita, Bruna M., et al.
Publicado: (2022)

When left does not seem right: epigenetic and bioelectric differences between left- and right-sided breast cancer
por: Masuelli, Sofía, et al.
Publicado: (2022)

Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer
por: Chen, Chen, et al.
Publicado: (2021)

Correction to: When left does not seem right: epigenetic and bioelectric differences between left and right‑sided breast cancer
por: Masuelli, Sofia, et al.
Publicado: (2022)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
por: Liu, Ning Qing, et al.
Publicado: (2014)

Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers
por: Pannu, Vaishali, et al.
Publicado: (2015)

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
por: Jansson, Sara, et al.
Publicado: (2018)

Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
por: Llinàs-Arias, Pere, et al.
Publicado: (2017)

Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer
por: Oshi, Masanori, et al.
Publicado: (2022)

Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report
por: Marzese, Diego M, et al.
Publicado: (2011)

Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer
por: Handa, Tadashi, et al.
Publicado: (2019)

HOXB7 Overexpression Leads Triple-Negative Breast Cancer Cells to a Less Aggressive Phenotype
por: de Bessa Garcia, Simone Aparecida, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_44nn8e507ctk3cee28bdhevpqu